New Agents In Combination With Revlimid Show Promise For Relapsed ... The Myeloma Beacon Afinitor is currently used to prevent transplant rejection and to treat some types of kidney cancers. Before 2010, there had been no research into the efficacy of Afinitor in treating multiple myeloma. The authors of the review evaluated a Phase 1 ... |
